Nasdaq trade halt continues; reason not available at 03:58 a.m.
SUPN•Trading in Supernus Pharmaceuticals continued to be halted on Nasdaq; the reason was not available at 03:58 a.m.
Related News
Xpeng schedules third-quarter financial results release
XPEV•
First Solar: Barclays cuts target price to $230 from $259
FSLR•
Cameco Corporation: Barclays cuts target price to $89 from $95
CCJ•
Nasdaq trade halt continues, reason not available at 03:58 a.m.
RETO•
JPMorgan raises total voting rights in Bodycote to 9.83% from 9.61%
JPM•